Trials / Completed
CompletedNCT00000452
Naltrexone Treatment of Alcohol Dependence
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 240 (planned)
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The long-range goal of this ongoing research program is to find more effective treatments for alcohol dependence by combining medication with the appropriate psychosocial support. This proposal has three specific aims: (1) to compare the effectiveness of naltrexone (Revia) in three types of treatment settings; (2) to assess the effects of psychosocial support on medication compliance and treatment retention; and (3) to investigate the individual characteristics that may predict who is likely to benefit from additional psychosocial support versus simple medication management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | naltrexone (Revia) | |
| BEHAVIORAL | Compliance Enhancement Tech. | |
| BEHAVIORAL | Cognitive Behavior Therapy |
Timeline
- Completion
- 2003-01-01
- First posted
- 1999-11-03
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000452. Inclusion in this directory is not an endorsement.